For Immediate Release
Contact: Kaylyn Kendall Dines
At UMDNJ-Robert Wood Johnson Medical School
Researchers Seek Minority Women with Depression and Low Sexual
Desire for Study
Researchers at the University
of Medicine and Dentistry of New Jersey (UMDNJ) are seeking minority
women who have been diagnosed with depression for a study designed
to treat low sexual desire.
The clinical trial will test Wellbutrin, an anti-depressant
medication that contains dopamine. This chemical appears to increase
The UMDNJ-Robert Wood Johnson Medical School is the only site
nationally conducting this 10-week study. Dr. Matthew Menza, professor
and vice chairman of psychiatry at the UMDNJ-Robert Wood Johnson
Medical School, and Dr. Roseanne Dobkin, post-doctoral fellow
in clinical psychopharmacology, are co-principal investigators.
Dr. Menza, a nationally recognized expert on behavioral health,
said, "We have little data that illustrates how minority women
respond to treatment for sexual concerns. This study should help
provide physicians with information about effective treatments
for low sexual desire in this population of women."
The research team is seeking 20 African-American, Hispanic or
Asian-American women between ages 18 and 65 who have been taking
an anti-depressant medication for at least eight weeks and have
experienced low sexual desire.
For more information about the study, contact Dr. Dobkin at
The University of Medicine and Dentistry of New Jersey (UMDNJ)
comprises eight schools. The are New Jersey's only three medical
schools, the state's only dental school, a school of health related
professions, a school of nursing, a graduate school of biomedical
sciences, and a school of public health on campuses in Newark,
Piscataway/New Brunswick, Camden, Stratford, and Scotch Plains.
UMDNJ also operates University Behavioral HealthCare. It is affiliated
with more than 200 health care and educational institutions throughout